3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
17
Multiple Myeloma
12
Ovarian Neoplasms
9
Recurrence
8
Lymphoma, B-Cell
8
Pancreatic Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma
7
Hodgkin Disease
7
Burkitt Lymphoma
7
Colorectal Neoplasms
6
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Biphenotypic, Acute
5
Stomach Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia
4
Hematologic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urogenital Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Osteosarcoma
3
Melanoma
3
Lymphoma, Follicular
3
Leukemia, B-Cell
3
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
lutetium Lu 177 dotatate
2
Bevacizumab
2
regorafenib
1
olaparib
1
neratinib
1
gallium Ga 68 dotatate
1
capivasertib
1
cabozantinib
1
brigatinib
1
abemaciclib
1
Watchful Waiting
1
Tablets
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Protons
1
Proton Therapy
1
Observation
1
Nivolumab
1
Lysine
1
Ipilimumab
1
Hydroxyurea
1
HhAntag691
1
Ga(III)-DOTATOC
1
GSK2256098
1
Everolimus
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
fludarabine
×
30 days
×
Clear all
No trials found.